Cultivation Capital Life Sciences provides late seed/Series A venture funding to life science related companies. We are interested in opportunities in Healthcare IT and Services, Medical Devices, Pharmaceutical/Biotech, Biomedical Research Tools/reagents/Diagnostics, .

Consulting Services: Strategy and Innovation for Life Science Companies Over 35 years experience in both early stage ventures and Fortune 500 multinational corporations, with expertise in technical development/commercialization, general management & P&L responsibilities, and international scope.

API SERVICESApertus is managed and staffed by highly experienced people with relevant backgrounds with fine chemicals, biotech and pharmaceutics. Let us help you with your API needs.FORMULATION DEVELOPMENTOur team has experience developing sterile injectables, potent fomulations, nasal sprays, DEA regulated products, topical creams, liquids, tablets capsules and suppositories.CONTRACT MANUFACTURINGApertus specializes in manufacturing suppositories, capsule, tablet and topical products. We manufacture small to medium sized batches of prescription drug products in our FDA-inspected Saint Louis facility.ANALYTICAL DEVELOPMENTOur team has experience developing and validating HPLC, GC, wet bench, and dissolution tests for API and drug product release testing. Nearly all of our own release testing is performed in-house.

Drug Discovery and Development provides products and services to advance the discovery and development of NCE's and Biopharmaceuticals..

LINCO was a leader in the development and commercialization of research diagnostic kits (RIA, ELISA and Luminex xMAP platforms). It was acquired in May 2006 by Serologicals. Serologicals was acquired by Millipore in July 2006.

Responsible for global commercial development of novel vaccines and new products/services to support the Innovoject vaccination system..

Director International Marketing 1993-1996Director Strategic Planning 1991-1993Director Product/Commercial Development 1987-1991Manager R&D 1982-86